Title:
【発明の名称】3-(2,2,2-トリメチルヒドラジニウム)プロピオネートとガンマ-ブチロベタインを含有する心臓血管疾患の治療のための医薬組成物
Document Type and Number:
Japanese Patent JP3072858
Kind Code:
B2
Abstract:
PCT No. PCT/LV96/00002 Sec. 371 Date Feb. 19, 1998 Sec. 102(e) Date Feb. 19, 1998 PCT Filed Aug. 20, 1996 PCT Pub. No. WO97/06794 PCT Pub. Date Feb. 27, 1997A pharmaceutical composition containing 3-(2,2,2-trimethylhydrazinium)propionate and gamma -butyrobetaine with a pharmaceutically acceptable carrier for the treatment of cardiovascular diseases is disclosed. The composition may be for oral, parenteral, subcutaneous or rectal administration and exhibits low toxicity and a wide interval of therapeutic action safety.
Inventors:
Calvinche, Ibals
Beberis, maris
Beberis, maris
Application Number:
JP50917197A
Publication Date:
August 07, 2000
Filing Date:
August 20, 1996
Export Citation:
Assignee:
Calvinche, Ibals
Beberis, maris
Beberis, maris
International Classes:
A61K31/14; A61K31/195; A61K31/205; A61P9/00; A61P9/06; A61K9/08; A61P9/10; A61P9/12; (IPC1-7): A61K31/205; A61P9/00; A61P9/06; A61P9/10; A61P9/12
Attorney, Agent or Firm:
Takashi Ishida (3 others)